Strengthens Intellectual Property Portfolio and Provides Protection for Therapeutic Combination in Acclaim-3 Clinical Trial AUSTIN, Texas, Nov. 18, 2025 /PRNewswire/ ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its East Coast ...

The inventor of base and prime editing shares insights on medicine's efforts to make serious genetic diseases treatable or ...

Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

At the Mayo Clinic, cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are uncovering the earliest signs ...

Cincinnati Children's dedicated a new research center in Sharonville to finding treatments for patients with cancer, blood ...

A rare disease that has cut off children from the outside world now potentially has a cure. A clinical trial to treat severe ...

Sharonville, Ohio, celebrates the opening of the new Cincinnati Children's Applied Gene and Cell Therapy Center.

Cincinnati Children's today celebrated the opening of a new state-of-art facility for its Applied Gene and Cell Therapy Center, which will enable the health system to increase clinical trials of ...